- Search results for 870281-82-6
Cookie preferences
This website uses cookies, which are necessary for the technical operation of the website and are always set. Other cookies, which increase the comfort when using this website, are used for direct advertising or to facilitate interaction with other websites and social networks, are only set with your consent.
Configuration
Technically required
These cookies are necessary for the basic functions of the shop.
"Allow all cookies" cookie
"Decline all cookies" cookie
CSRF token
Cookie preferences
Currency change
Customer-specific caching
FACT-Finder tracking
Individual prices
Selected shop
Session
Comfort functions
These cookies are used to make the shopping experience even more appealing, for example for the recognition of the visitor.
Note
Show the facebook fanpage in the right blod sidebar
Statistics & Tracking
Affiliate program
Conversion and usertracking via Google Tag Manager
Track device being used
3 products were found matching "870281-82-6"!
Close filters
Filter by:
No results were found for the filter!
Item number: Cay15279-5
The phosphatidylinositol 3-kinase (PI3K) signaling pathway has central roles in cell growth, development, and survival. CAL-101 is a cell permeable inhibitor of the PI3K catalytic subunit p110delta (IC50 = 2.5 nM) that demonstrates 40- to 300-fold selectivity against other PI3K class I enzymes (IC50s = 820, 565, and...
Keywords: | Idelalisib, GS-1101, 5-fluoro-3-phenyl-2-[(1S)-1-(9H-purin-6-ylamino)propyl]-4(3H)-quinazolinone |
Application: | Cell permeable PIK3CD inhibitor |
CAS | 870281-82-6 |
MW: | 415.4 D |
From 44.00€
*
Item number: LC-I-7447_25mg
Soluble in DMSO
Keywords: | Idelalisib, GS-1101, 5-fluoro-3-phenyl-2-[(1S)-1-(9H-purin-6-ylamino)propyl]-4(3H)-quinazolinone |
Application: | Cell permeable PIK3CD inhibitor |
CAS | 870281-82-6 |
MW: | 415,42 D |
From 90.00€
*
Item number: LKT-C0044.1
CAL101 is an inhibitor of p110 PI3K that is currently under examination as a potential treatment for leukemias such as mantle cell lymphoma and chronic lymphocytic leukemia (CLL). CAL101 exhibits anticancer chemotherapeutic and immunosuppressive activities. In mantle cell lymphoma cells, CAL101 induces G1 phase...
Keywords: | Idelalisib, GS1101 |
Application: | PI3K p110 delta inhibitor |
CAS | 870281-82-6 |
MW: | 415.42 D |
From 84.00€
*